0001305773-22-000037.txt : 20220323
0001305773-22-000037.hdr.sgml : 20220323
20220323162209
ACCESSION NUMBER: 0001305773-22-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220314
FILED AS OF DATE: 20220323
DATE AS OF CHANGE: 20220323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pedulla Denise E
CENTRAL INDEX KEY: 0001804602
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37474
FILM NUMBER: 22763469
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Conformis Inc
CENTRAL INDEX KEY: 0001305773
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 TECHNOLOGY DRIVE
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: (781) 345-9001
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY DRIVE
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: ConforMIS Inc
DATE OF NAME CHANGE: 20041013
4
1
wf-form4_164806691657223.xml
FORM 4
X0306
4
2022-03-14
0
0001305773
Conformis Inc
CFMS
0001804602
Pedulla Denise E
C/O CONFORMIS INC
600 TECHNOLOGY PARK DRIVE
BILLERICA
MA
01821
0
1
0
0
CLO & SECRETARY
Common Stock
2022-03-14
4
A
0
450000
0
A
450000
D
Stock Option (right to buy)
0.61
2022-03-14
4
A
0
450000
0
A
2023-03-14
2032-03-14
Common Stock
450000.0
450000
D
Represents an inducement grant award of restricted stock units to the Reporting Person in connection with her appointment as CLO and Secretary. The restricted stock units vest over eight years, with the following schedule: 8%, 10%, 15%, 20%, 20%, 15%, 8% and 4% of the total number of shares vesting on each one-year anniversary of the grant date, subject to the Reporting Person's continued service as an employee of Conformis through the applicable vesting dates, and are subject to certain forfeiture provisions.
Represents an inducement grant award of options to the Reporting Person in connection with her appointment as CLO and Secretary. The option to purchase an aggregate of 450,000 shares of Issuer's common stock vests over eight years, with the following schedule: 8%, 10%, 15%, 20%, 20%, 15%, 8% and 4% of the total number of shares underlying the option vesting on each one-year anniversary of the grant date, subject to the Reporting Person's continued service as an employee of Conformis through the applicable vesting dates, and are subject to the certain forfeiture provisions.
Denise E. Pedulla
2022-03-23